Cleveland BioLabs Announces Date Change for Second Quarter 2015 Financial Results
31. Juli 2015 13:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jul 31, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on August 12, 2015, it will report its financial results for the second quarter and...
Cleveland BioLabs to Report Second Quarter 2015 Financial Results on August 3
21. Juli 2015 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jul 21, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on August 3, 2015, it will report its financial results for the second quarter and...
Cleveland BioLabs Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement
16. Juli 2015 08:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jul 16, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that on July 15, 2015, the Company received a letter from The Nasdaq Stock Market LLC stating that...
Cleveland BioLabs Announces Results of Phase 1 Study of CBLB612 in Russian Federation
13. Juli 2015 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jul 13, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the results of a Phase 1 single-blinded, randomized, placebo-controlled, healthy-subject...
Cleveland BioLabs Announces Board Appointments
10. Juli 2015 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jul 10, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the appointment of Mses. Anna Evdokimova, Natalia Khudyk, Yulia Lebedina, Tatiana Levina,...
Cleveland BioLabs Closes Private Placement With Strategic Investor for $25 Million Equity Financing
09. Juli 2015 09:15 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jul 9, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has successfully closed a private placement with David Davidovich, a venture capital...
Cleveland BioLabs Enters Into Private Placement Agreement With Strategic Investor for $25 Million Equity Financing
25. Juni 2015 07:00 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jun 25, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that it has entered into a securities purchase agreement with David Davidovich, a venture...
Cleveland BioLabs Submits Pre-EUA Dossier for Entolimod to FDA
15. Juni 2015 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jun 15, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced that the company has submitted an application for pre-Emergency Use Authorization (pre-EUA) to the...
Cleveland BioLabs Releases Entolimod Phase 1 Study Findings at ASCO
01. Juni 2015 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - Jun 1, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today announced the release of results from a Phase 1 open-label, dose-escalation trial of entolimod in patients...
Cleveland BioLabs Reports First Quarter 2015 Financial Results and Development Progress
06. Mai 2015 07:30 ET
|
Cleveland BioLabs, Inc.
BUFFALO, NY--(Marketwired - May 6, 2015) - Cleveland BioLabs, Inc. (NASDAQ: CBLI) today reported financial results and development progress for the first quarter ended March 31, 2015.
...